{"name": "ugichem",
 "permalink": "ugichem",
 "crunchbase_url": "http://www.crunchbase.com/company/ugichem",
 "homepage_url": "http://www.ugichem.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "contact@ugichem.at",
 "phone_number": "43-(0)512-282285-10",
 "description": "",
 "created_at": "Sat Mar 20 04:32:35 UTC 2010",
 "updated_at": "Wed May 29 02:54:47 UTC 2013",
 "overview": "\u003Cp\u003Eugichem is an innovative biotech company based on unique chemistry and focused on the development of novel antisense drugs. Their mission is to turn antisense into therapeutics. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       48],
      "assets/images/resized/0008/1044/81044v1-max-150x150.jpg"],
     [[250,
       80],
      "assets/images/resized/0008/1044/81044v1-max-250x250.jpg"],
     [[315,
       101],
      "assets/images/resized/0008/1044/81044v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.33M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 1080000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 5,
    "funded_day": 17,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "BioScience Ventures Group",
         "permalink": "bioscience-ventures-group",
         "image":
          {"available_sizes":
            [[[150,
               48],
              "assets/images/resized/0008/1051/81051v1-max-150x150.jpg"],
             [[250,
               80],
              "assets/images/resized/0008/1051/81051v1-max-250x250.jpg"],
             [[285,
               92],
              "assets/images/resized/0008/1051/81051v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "private_equity",
    "source_url": "http://pevc.dowjones.com/article?an=DJFVW00020130528e95spptue\u0026from=alert\u0026pid=32\u0026ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020130528e95spptue%26from%3dalert%26pid%3d32",
    "source_description": "Ugichem Raises EUR2.25M for Inflammatory Disease Therapies ",
    "raised_amount": 2250000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 28,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Mitterweg 24",
    "address2": "",
    "zip_code": "A-6020",
    "city": "Innsbruck",
    "state_code": null,
    "country_code": "AUT",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        111],
       "assets/images/resized/0008/1045/81045v1-max-150x150.jpg"],
      [[250,
        185],
       "assets/images/resized/0008/1045/81045v1-max-250x250.jpg"],
      [[450,
        334],
       "assets/images/resized/0008/1045/81045v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}